ORELABRUTINIB for Central nervous system lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 31 adverse event reports in the FDA FAERS database where ORELABRUTINIB was used for Central nervous system lymphoma.

Most Reported Side Effects for ORELABRUTINIB

Side Effect	Reports	%	Deaths	Hosp.
Anaemia	54	41.2%	8	5
Hypokalaemia	40	30.5%	2	0
Pneumonia	35	26.7%	8	3
Neutropenia	30	22.9%	3	0
Thrombocytopenia	26	19.9%	5	0
Disease progression	14	10.7%	3	0
Covid-19	11	8.4%	8	0
Platelet count decreased	11	8.4%	4	7
Drug ineffective	10	7.6%	6	0
Myelosuppression	10	7.6%	1	3
Product use in unapproved indication	8	6.1%	1	0
White blood cell count decreased	8	6.1%	1	2
Atrial fibrillation	7	5.3%	1	0
Febrile neutropenia	7	5.3%	2	0
Neutrophil count decreased	7	5.3%	1	2